1
|
Yi H, Chen T, He G, Liu L, Zhao J, Guo K, Cao Y, Sun P, Zhou X, Zhang B, Li C, Wang H. Retinoic acid mitigates the NSC319726-induced spermatogenesis dysfunction through cuproptosis-independent mechanisms. Cell Biol Toxicol 2024; 40:26. [PMID: 38691186 PMCID: PMC11062974 DOI: 10.1007/s10565-024-09857-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2024] [Accepted: 03/25/2024] [Indexed: 05/03/2024]
Abstract
Copper ionophore NSC319726 has attracted researchers' attention in treating diseases, particularly cancers. However, its potential effects on male reproduction during medication are unclear. This study aimed to determine whether NSC319726 exposure affected the male reproductive system. The reproductive toxicity of NSC319726 was evaluated in male mice following a continuous exposure period of 5 weeks. The result showed that NSC319726 exposure caused testis index reduction, spermatogenesis dysfunction, and architectural damage in the testis and epididymis. The exposure interfered with spermatogonia proliferation, meiosis initiation, sperm count, and sperm morphology. The exposure also disturbed androgen synthesis and blood testis barrier integrity. NSC319726 treatment could elevate the copper ions in the testis to induce cuproptosis in the testis. Copper chelator rescued the elevated copper ions in the testis and partly restored the spermatogenesis dysfunction caused by NSC319726. NSC319726 treatment also decreased the level of retinol dehydrogenase 10 (RDH10), thereby inhibiting the conversion of retinol to retinoic acid, causing the inability to initiate meiosis. Retinoic acid treatment could rescue the meiotic initiation and spermatogenesis while not affecting the intracellular copper ion levels. The study provided an insight into the bio-safety of NSC319726. Retinoic acid could be a potential therapy for spermatogenesis impairment in patients undergoing treatment with NSC319726.
Collapse
Affiliation(s)
- Haisheng Yi
- Department of Andrology, The First Hospital of Jilin University, Jilin University, Changchun, 130012, China
| | - Tong Chen
- College of Animal Sciences, Jilin University, Changchun, 130062, China
| | - Guitian He
- College of Animal Sciences, Jilin University, Changchun, 130062, China
| | - Lingyun Liu
- Department of Andrology, The First Hospital of Jilin University, Jilin University, Changchun, 130012, China
| | - Jiantao Zhao
- Department of Andrology, The First Hospital of Jilin University, Jilin University, Changchun, 130012, China
| | - Kaimin Guo
- Department of Andrology, The First Hospital of Jilin University, Jilin University, Changchun, 130012, China
| | - Yin Cao
- Department of Andrology, The First Hospital of Jilin University, Jilin University, Changchun, 130012, China
| | - Penghao Sun
- Department of Andrology, The First Hospital of Jilin University, Jilin University, Changchun, 130012, China
| | - Xu Zhou
- College of Animal Sciences, Jilin University, Changchun, 130062, China.
| | - Boqi Zhang
- College of Animal Sciences, Jilin University, Changchun, 130062, China.
| | - Chunjin Li
- College of Animal Sciences, Jilin University, Changchun, 130062, China.
| | - Hongliang Wang
- Department of Andrology, The First Hospital of Jilin University, Jilin University, Changchun, 130012, China.
| |
Collapse
|
2
|
Yu X, Kogan S, Chen Y, Tsang AT, Withers T, Lin H, Gilleran J, Buckley B, Moore D, Bertino J, Chan C, Kimball SD, Loh SN, Carpizo DR. Zinc Metallochaperones Reactivate Mutant p53 Using an ON/OFF Switch Mechanism: A New Paradigm in Cancer Therapeutics. Clin Cancer Res 2018; 24:4505-4517. [PMID: 29914895 DOI: 10.1158/1078-0432.ccr-18-0822] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2018] [Revised: 05/17/2018] [Accepted: 06/04/2018] [Indexed: 01/04/2023]
Abstract
Purpose: Zinc metallochaperones (ZMC) are a new class of anticancer drugs that reactivate zinc-deficient mutant p53 by raising and buffering intracellular zinc levels sufficiently to restore zinc binding. In vitro pharmacodynamics of ZMCs indicate that p53-mutant activity is ON by 4-6 hours and is OFF by 24. We sought to understand the mechanism of this regulation and to translate these findings preclinically. We further sought to innovate the formulation of ZMCs to improve efficacy.Experimental Design: We performed in vitro mechanistic studies to determine the role of cellular zinc homeostatic mechanisms in the transient pharmacodynamics of ZMCs. We conducted preclinical pharmacokinetic, pharmacodynamic, and efficacy studies using a genetically engineered murine pancreatic cancer model (KPC) to translate these mechanistic findings and investigate a novel ZMC formulation.Results:In vitro, cellular zinc homeostatic mechanisms that restore zinc to its physiologic levels function as the OFF switch in ZMC pharmacodynamics. In vivo pharmacokinetic studies indicate that ZMCs have a short half-life (< 30 minutes), which is sufficient to significantly improve survival in mice expressing a zinc-deficient allele (p53R172H) while having no effect in mice expressing a non-zinc-deficient allele (p53R270H). We synthesized a novel formulation of the drug in complex with zinc and demonstrate this significantly improves survival over ZMC1.Conclusions: Cellular zinc homeostatic mechanisms function as an OFF switch in ZMC pharmacodynamics, indicating that a brief period of p53-mutant reactivation is sufficient for on-target efficacy. ZMCs synthesized in complex with zinc are an improved formulation. Clin Cancer Res; 24(18); 4505-17. ©2018 AACR.
Collapse
Affiliation(s)
- Xin Yu
- Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.,Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
| | - Samuel Kogan
- Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.,Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.,Department of Pharmacology, Rutgers University, Piscataway, New Jersey
| | - Ying Chen
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
| | - Ashley T Tsang
- Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.,Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.,Mount Sinai St. Luke's Roosevelt General Surgery Residency Program, New York, New York
| | - Tracy Withers
- Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.,Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
| | - Hongxia Lin
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
| | - John Gilleran
- Department of Medicinal Chemistry, Rutgers Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey
| | - Brian Buckley
- Rutgers Environmental and Occupational Health Sciences Institute, Rutgers University, Piscataway, New Jersey
| | - Dirk Moore
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.,Department of Biostatistics. Rutgers School of Public Health, Rutgers University, New Brunswick, New Jersey
| | - Joseph Bertino
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.,Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey
| | - Chang Chan
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.,Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey
| | - S David Kimball
- Mount Sinai St. Luke's Roosevelt General Surgery Residency Program, New York, New York.,Rutgers Translational Sciences, Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, New Jersey.,Z53 Therapeutics, Inc, Holmdel, New Jersey
| | - Stewart N Loh
- Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, New York
| | - Darren R Carpizo
- Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey. .,Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.,Department of Pharmacology, Rutgers University, Piscataway, New Jersey.,Z53 Therapeutics, Inc, Holmdel, New Jersey
| |
Collapse
|
3
|
Shimada K, Reznik E, Stokes ME, Krishnamoorthy L, Bos PH, Song Y, Quartararo CE, Pagano NC, Carpizo DR, deCarvalho AC, Lo DC, Stockwell BR. Copper-Binding Small Molecule Induces Oxidative Stress and Cell-Cycle Arrest in Glioblastoma-Patient-Derived Cells. Cell Chem Biol 2018; 25:585-594.e7. [PMID: 29576531 PMCID: PMC5959763 DOI: 10.1016/j.chembiol.2018.02.010] [Citation(s) in RCA: 65] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2017] [Revised: 01/02/2018] [Accepted: 02/18/2018] [Indexed: 12/15/2022]
Abstract
Transition metals are essential, but deregulation of their metabolism causes toxicity. Here, we report that the compound NSC319726 binds copper to induce oxidative stress and arrest glioblastoma-patient-derived cells at picomolar concentrations. Pharmacogenomic analysis suggested that NSC319726 and 65 other structural analogs exhibit lethality through metal binding. Although NSC319726 has been reported to function as a zinc ionophore, we report here that this compound binds to copper to arrest cell growth. We generated and validated pharmacogenomic predictions: copper toxicity was substantially inhibited by hypoxia, through an hypoxia-inducible-factor-1α-dependent pathway; copper-bound NSC319726 induced the generation of reactive oxygen species and depletion of deoxyribosyl purines, resulting in cell-cycle arrest. These results suggest that metal-induced DNA damage may be a consequence of exposure to some xenobiotics, therapeutic agents, as well as other causes of copper dysregulation, and reveal a potent mechanism for targeting glioblastomas.
Collapse
Affiliation(s)
- Kenichi Shimada
- Department of Biological Sciences, Columbia University, New York, NY 10027, USA
| | - Eduard Reznik
- Department of Biological Sciences, Columbia University, New York, NY 10027, USA
| | - Michael E Stokes
- Department of Biological Sciences, Columbia University, New York, NY 10027, USA
| | - Lakshmi Krishnamoorthy
- Howard Hughes Medical Institute, Department of Chemistry, University of California, Berkeley, CA 94720, USA
| | - Pieter H Bos
- Department of Biological Sciences, Columbia University, New York, NY 10027, USA
| | - Yuyu Song
- Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA
| | | | - Nen C Pagano
- Department of Biological Sciences, Columbia University, New York, NY 10027, USA
| | - Darren R Carpizo
- Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA
| | - Ana C deCarvalho
- Department of Neurosurgery, Henry Ford Hospital, Detroit, MI 48202, USA
| | - Donald C Lo
- Center for Drug Discovery and Department of Neurobiology, Duke University Medical Center, Durham, NC 27710, USA
| | - Brent R Stockwell
- Department of Biological Sciences, Columbia University, New York, NY 10027, USA; Department of Chemistry, Columbia University, New York, NY 10027, USA.
| |
Collapse
|
4
|
Gao X, Zhang Y, Wang Y, Zhang Y, Wang Y, Liu S, Gao X. Influence of verapamil on pharmacokinetics of pristimerin in rats. Biomed Chromatogr 2015; 30:802-9. [PMID: 26347996 DOI: 10.1002/bmc.3611] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2015] [Revised: 08/18/2015] [Accepted: 09/03/2015] [Indexed: 11/09/2022]
Affiliation(s)
- Xiaodong Gao
- Department of General Surgery; Pizhou City People's Hospital; Pizhou City 221300 Jiangsu Province China
- Department of Emergency Surgery; Shanghai Putuo District Central Hospital; Shanghai 200062 China
| | - Yongjie Zhang
- Biliary Tract Surgery Department 2, Eastern Hepatobiliary Surgery Hospital; Second Military Medical University; Shanghai 200430 China
| | - Yongdong Wang
- Department of orthopedics; Pizhou Traditional Chinese Medicine Hospital; Pizhou City 221300 Jiangsu Province China
| | - Yijie Zhang
- Department of General Surgery; Changhai Hospital, Second Military Medical University; Shanghai 200433 China
| | - Yixin Wang
- Department of Emergency Surgery; Shanghai Putuo District Central Hospital; Shanghai 200062 China
| | - Shuya Liu
- Department of General Surgery; Pizhou City People's Hospital; Pizhou City 221300 Jiangsu Province China
| | - Xiaohong Gao
- Department of Medical Oncology; Pizhou Traditional Chinese Medicine Hospital; Pizhou City 221300 Jiangsu Province China
| |
Collapse
|